(Q45887207)

17 December 2017

title

HER2 peptide-specific CD8(+) T cells are proportionally detectable long after multiple DNA vaccinations (English)

1 reference

17 December 2017

author name string

Mukai K

1

1 reference

17 December 2017

Yasutomi Y

2

1 reference

17 December 2017

Watanabe M

3

1 reference

17 December 2017

Kenjo A

4

1 reference

17 December 2017

Aota T

5

1 reference

17 December 2017

Wang L

6

1 reference

17 December 2017

Nishikawa H

7

1 reference

17 December 2017

Ishihara M

8

1 reference

17 December 2017

Fujita T

9

1 reference

17 December 2017

Kuribayashi K

10

1 reference

17 December 2017

Shiku H

11

1 reference

17 December 2017

publication date

1 July 2002

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

13

1 reference

17 December 2017

page(s)

879-888

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301707

exact match

0 references

cites work

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

CD4 T cells and their role in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Epitope affinity for MHC class I determines helper requirement for CTL priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

DNA vaccination against neu reduces breast cancer incidence and metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Selection of highly transfectable variant from mouse mastocytoma P815.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

A rapid method for the isolation of functional thymus-derived murine lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

inferred from DOI database lookup

7 January 2021

based on heuristic

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

inferred from DOI database lookup

7 January 2021

based on heuristic

A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFNgamma-producing T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301707

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3301707

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017